相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prostaglandin E2 Inhibits Histamine-Evoked Ca2+ Release in Human Aortic Smooth Muscle Cells through Hyperactive cAMP Signaling Junctions and Protein Kinase A
Emily J. A. Taylor et al.
MOLECULAR PHARMACOLOGY (2017)
The molecular targets of approved treatments for pulmonary arterial hypertension
Marc Humbert et al.
THORAX (2016)
The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor
Sharonjit K. Gill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A
Ramy Habashy Malty et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype
Mark A. Birrell et al.
THORAX (2015)
Pioglitazone, a PPAR agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling
Yuan Yang et al.
MOLECULAR CARCINOGENESIS (2015)
Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase
Ying-Ju Lai et al.
PLOS ONE (2015)
Prostaglandin E2 Inhibits Elastogenesis in the Ductus Arteriosus via EP4 Signaling
Utako Yokoyama et al.
CIRCULATION (2014)
Important role of PLC-γ1 in hypoxic increase in intracellular calcium in pulmonary arterial smooth muscle cells
Vishal R. Yadav et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Ca2+ signals evoked by histamine H1 receptors are attenuated by activation of prostaglandin EP2 and EP4 receptors in human aortic smooth muscle cells
Evangelia Pantazaka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
E-type prostanoid receptor 4 (EP4) in disease and therapy
Viktoria Konya et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Molecular pathogenesis of pulmonary arterial hypertension
Marlene Rabinovitch
JOURNAL OF CLINICAL INVESTIGATION (2012)
HYPOXIC PULMONARY VASOCONSTRICTION
J. T. Sylvester et al.
PHYSIOLOGICAL REVIEWS (2012)
Cilostazol Promotes Vascular Smooth Muscles Cell Differentiation Through the cAMP Response Element-Binding Protein-Dependent Pathway
Wei-Jan Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Mechanisms of disease: pulmonary arterial hypertension
Ralph T. Schermuly et al.
NATURE REVIEWS CARDIOLOGY (2011)
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2011)
Treatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs
Zeenat Safdar
RESPIRATORY MEDICINE (2011)
EP4 receptor as a new target for bronchodilator therapy
James Buckley et al.
THORAX (2011)
Smooth Muscle Proliferation and Role of the Prostacyclin (IP) Receptor in Idiopathic Pulmonary Arterial Hypertension
Emilia Falcetti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension
Kamal K. Mubarak
RESPIRATORY MEDICINE (2010)
Pharmacological activation of the prostaglandin E-2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury
Keiichi Hishikari et al.
CARDIOVASCULAR RESEARCH (2009)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension
Ying-Ju Lai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Vasorelaxation induced by prostaglandin E2 in human pulmonary vein:: role of the EP4 receptor subtype
N. Foudi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension
Georg Hansmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases
Florence Gizard et al.
PPAR RESEARCH (2008)
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
Joseph T. Crossno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-γ activation
Georg Hansmann et al.
CIRCULATION (2007)
Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
Ralph T. Schermuly et al.
RESPIRATORY RESEARCH (2007)
Peroxisome Proliferator Activated Receptor Ligands as Regulators of Airway Inflammation and Remodelling in Chronic Lung Disease
Jane Elizabeth Ward et al.
PPAR RESEARCH (2007)
Role of prostacyclin versus peroxisome proliferator-activated receptor β receptors in prostacyclin sensing by lung fibroblasts
FY Ali et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Piglet saphenous vein contains multiple relaxatory prostanoid receptors:: evidence for EP4, EP2, DP and IP receptor subtypes
RJ Wilson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Spontaneous Ca2+ oscillations in subcellular compartments of vascular smooth muscle cells rely on different Ca2+ pools
OD Fedoryak et al.
CELL RESEARCH (2004)
Protective effect of propylthiouracil independent of its hypothyroid effect on atherogenesis in cholesterol-fed rabbits - PTEN induction and inhibition of vascular smooth muscle cell proliferation and migration
WJ Chen et al.
CIRCULATION (2004)
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
AN Hata et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Functional pharmacology of human prostanoid EP2 and EP4 receptors
RJ Wilson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Prostacyclin and its analogues in the treatment of pulmonary hypertension
H Olschewski et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Peroxisome proliferator-activated receptor γ inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells
D Bruemmer et al.
MOLECULAR ENDOCRINOLOGY (2003)
Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth
S Ameshima et al.
CIRCULATION RESEARCH (2003)
Discovery of a potent and selective agonist of the prostaglandin EP4 receptor
X Billot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Expression and function of PPARγ in rat and human vascular smooth muscle cells
RE Law et al.
CIRCULATION (2000)
分享论文
